Conducting clinical research studies with
SKILL, KNOWLEDGE and SAFETY.
Call to participate
860.443.4567

Female Sexual Function and Dysfunction

HSDD3

When most of us think of sex, we conjure up images of romance, love, and possibly lust. But what happens if a woman’s interest in sex fades, if sexual thoughts and fantasies are just a memory?  What should be done when a woman’s desire to be sexual has left and she no longer feels responsive to her partner’s advances? This all depends on how the change affects the woman in question. One woman may consider it a natural and normal life progression, while for another the loss becomes a source of personal distress.

For the research scientist, talk of romance and love and lust is translated into “the sexual response cycle” – desire, arousal, plateau, orgasm and resolution. It sounds so clinical, but it serves a purpose in research as different approaches may be necessary for problems that arise in each phase of that cycle. Research is being conducted to find solutions for those women who develop distress when experiencing the common changes described above. Currently we are focused on the desire phase of the cycle, from which arousal and orgasm will hopefully flow.

Hypoactive Sexual Desire Disorder (HSDD) is defined as “the persistent or recurrent deficiency (or absence) of sexual fantasies/thoughts, and/or desire for or receptivity to sexual activity, which causes personal distress.” We are currently conducting a clinical trial of an investigational medication for treatment of HSDD. As with most research into treatment of this problem, we are focused on women who previously had what they felt was a satisfying level of interest in sex, but who have become distressed with experiencing a decrease in interest. Women who have always had a low level of interest in sex are thought to be less likely to benefit from the medications currently being studied

Call 860-443-4567 to learn more about our current clinical trial for HSDD or e-mail marylou@ccrstudies.com to learn more.

The study is being conducted by Robert M. Spitz, MD, Craig E. McKnight, MD, PhD, and Merrilyn McNatt, APRN.